MVIP
AGN

Mar Vista Investment Partners’s Allergan Inc AGN Stock Holding History

Mar Vista Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-318,017
Closed -$67.6M – 64
2014
Q4 		$67.6M Buy
318,017
+94,859
+43% +$18.9M 3.96% 9
2014
Q3 		$39.8M Sell
223,158
-2,215
-1% -$368K 2.44% 19
2014
Q2 		$38.1M Sell
225,373
-291,259
-56% -$45.3M 2.37% 18
2014
Q1 		$64.1M Buy
516,632
+10,802
+2% +$1.32M 3.69% 12
2013
Q4 		$56.2M Buy
505,830
+29,937
+6% +$2.86M 3.27% 14
2013
Q3 		$43M Sell
475,893
-47,824
-9% -$4.29M 2.96% 16
2013
Q2 		$44.1M Buy
+523,717
New +$54.3M 2.87% 20

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Mar Vista Investment Partners's AGN Position: Q1 2015 in Review

Mar Vista Investment Partners sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 318,017 shares — an estimated $67.6M sold.

Mar Vista Investment Partners first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $67.6M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Mar Vista Investment Partners reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Mar Vista Investment Partners sold 318,017 Allergan Inc shares in Q1 2015, an estimated $67.6M.
  • Mar Vista Investment Partners first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Mar Vista Investment Partners's Allergan Inc position peaked at $67.6M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Mar Vista Investment Partners's 13F filing for Q1 2015, filed 30 Apr 2015.